R&D and Capital Expenditures, and Optimization of Assets and Invested Capital
First written in FY2016. 32 of 35 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Total capital expenditures in the semiconductor devices business during the fiscal year, including intangible assets as well as property, plant and equipment, were ¥2,273.339 million. Major expenditures comprised new capital investments related to the relocation of the company's head office and investments in equipment upgrades at Phenitec Semiconductor Co., Ltd., a consolidated subsidiary.」
Full-year capital expenditures of ¥2,273.339 million were recorded, with investment in the relocation of the head office and equipment upgrades at Phenitec. R&D expenditure was ¥343 million, and investment in R&D and capital expenditures is continuing. - 2026-05-14AdvancedEarnings
「We will use the funds for research and development, capital investment, investment in new business fields and maintaining our financial strength.」
The company presented a capital allocation policy of continuing investment in research and development, capital expenditure and new business fields. - FY2026-H1AdvancedAnnual report
「The group's total R&D expenditure for the interim consolidated period was ¥155 million.」
R&D expenditure of ¥155 million for the interim consolidated period was disclosed. In investing activities, ¥684 million was spent, including on the replacement of machinery and equipment at a subsidiary. - FY2025AdvancedAnnual report
「The total amount invested in R&D during the fiscal year was ¥595 million, covering the Japan segment. Total capital expenditures in the semiconductor devices business during the fiscal year, including intangible assets as well as property, plant and equipment, were ¥2,964.690 million.」
R&D expenditure of ¥595 million and capital expenditures of ¥2,964 million were recorded, and investment in R&D and manufacturing equipment continued. - FY2025-H1AdvancedAnnual report
「The group's total R&D expenditure for the interim consolidated period was ¥288 million.」
R&D expenditure of ¥288 million for the interim consolidated period was disclosed, up from ¥233 million in the same interim period of the previous year, and investment in R&D is continuing. - FY2024AdvancedAnnual report
「The total amount invested in R&D during the fiscal year was ¥520 million, covering the Japan segment.」
R&D expenditure of ¥520 million and capital expenditures of ¥5,284.322 million were recorded, with investment progressing in new equipment at the Kagoshima plant. - FY2024-Q3AdvancedAnnual report
「The group's total R&D expenditure for the current third-quarter cumulative consolidated period was ¥355 million.」
R&D expenditure of ¥355 million for the third-quarter cumulative consolidated period was disclosed, and investment in R&D is continuing. - FY2024-Q2AdvancedAnnual report
「The group's total R&D expenditure for the current second-quarter cumulative consolidated period was ¥233 million.」
R&D expenditure of ¥233 million for the second-quarter cumulative consolidated period was disclosed, and investment in R&D is continuing. The company stated that there had been no material changes in its R&D activities. - FY2024-Q1AdvancedAnnual report
「The group's total R&D expenditure for the current first-quarter cumulative consolidated period was ¥109 million.」
R&D expenditure was ¥109 million, up from ¥105 million in the same period of the previous year. Property, plant and equipment also increased by ¥785 million due to the introduction of new equipment at a subsidiary. - FY2023-Q3AdvancedAnnual report
「The group's total R&D expenditure for the current third-quarter cumulative consolidated period was ¥409 million.」
R&D expenditure of ¥409 million for the third-quarter cumulative consolidated period was disclosed, up from ¥316 million in the same period of the previous year. - FY2023-Q2AdvancedAnnual report
「The group's total R&D expenditure for the current second-quarter cumulative consolidated period was ¥253 million.」
R&D expenditure of ¥253 million for the second-quarter cumulative consolidated period was disclosed. The company stated that there had been no material changes in its R&D activities. - FY2023-Q1AdvancedAnnual report
「The group's total R&D expenditure for the current first-quarter cumulative consolidated period was ¥105 million.」
R&D expenditure of ¥105 million for the current first-quarter cumulative consolidated period was disclosed. The company stated that there had been no material changes in its R&D activities. - FY2022AdvancedAnnual report
「Total capital expenditures in the semiconductor devices business during the fiscal year, including intangible assets as well as property, plant and equipment, were ¥1,916.790 million. Major expenditures comprised the introduction of new equipment and investment in related facilities at the first and Kagoshima plants of Phenitec Semiconductor Co., Ltd., a consolidated subsidiary.」
Full-year capital expenditures amounted to ¥1,916.790 million, with investment in the introduction of new equipment and related areas at the first and Kagoshima plants. R&D expenditure was also disclosed at ¥464.857 million. - FY2022-Q3AdvancedAnnual report
「The group's total R&D expenditure for the current third-quarter cumulative consolidated period was ¥316 million.」
R&D expenditure of ¥316 million for the third-quarter cumulative consolidated period was disclosed, and investment in R&D is continuing. The company stated that there had been no material changes in its R&D activities. - FY2022-Q2AdvancedAnnual report
「The group's total R&D expenditure for the current second-quarter cumulative consolidated period was ¥202 million.」
R&D expenditure of ¥202 million for the second-quarter cumulative consolidated period was disclosed. The company also recorded ¥626 million in expenditures for the acquisition of property, plant and equipment and ¥148 million in expenditures for the acquisition of intangible assets. - FY2022-Q1AdvancedAnnual report
「The group's total R&D expenditure for the current first-quarter cumulative consolidated period was ¥100 million.」
R&D expenditure of ¥100 million for the current first-quarter cumulative consolidated period was disclosed, and investment in R&D is continuing. - FY2021AdvancedAnnual report
「The total amount invested in R&D during the fiscal year was ¥457 million, covering the Japan and North America segments. Total capital expenditures in the semiconductor devices business during the fiscal year, including intangible assets as well as property, plant and equipment, were ¥1,179.825 million.」
R&D expenditure of ¥457 million and capital expenditures of ¥1,179.825 million were recorded, with investment progressing in core systems, the consolidation of the first Phenitec plant and new equipment. - FY2021-Q3AdvancedAnnual report
「The group's total R&D expenditure for the current third-quarter cumulative consolidated period was ¥306 million.」
R&D expenditure of ¥306 million for the third-quarter cumulative consolidated period was disclosed. - FY2021-Q2AdvancedAnnual report
「The group's total R&D expenditure for the current second-quarter cumulative consolidated period was ¥189 million.」
R&D expenditure of ¥189 million for the current second-quarter cumulative consolidated period was disclosed, and investment in R&D is continuing. The company also recorded ¥901 million in expenditures for the acquisition of property, plant and equipment and ¥192 million in expenditures for the acquisition of intangible assets. - FY2021-Q1RestatedAnnual report
「The group's total R&D expenditure for the current first-quarter cumulative consolidated period was ¥69 million.」
R&D expenditure of ¥69 million for the current first-quarter cumulative consolidated period was disclosed. The company stated that there had been no material changes in its R&D activities. - FY2020AdvancedAnnual report
「Total capital expenditures in the semiconductor devices business during the fiscal year were ¥1,497.021 million. Major expenditures included software and related equipment for new product development, investments in a quality assurance environment suited to the target markets, and investments in the consolidation of factories to improve production efficiency.」
Full-year capital expenditures of ¥1,497 million and R&D expenditure of ¥403 million were disclosed, with investment progressing in new product development, quality assurance, factory consolidation and an investment in Cirel. - FY2020-Q3AdvancedAnnual report
「The group's total R&D expenditure for the current third-quarter cumulative consolidated period was ¥288 million.」
R&D expenditure of ¥288 million for the third-quarter cumulative consolidated period was disclosed, and investment in R&D is continuing. - FY2020-Q2AdvancedAnnual report
「The group's total R&D expenditure for the current second-quarter cumulative consolidated period was ¥182 million.」
R&D expenditure of ¥182 million for the current second-quarter cumulative consolidated period was disclosed, and investment in R&D is continuing. The company also recorded ¥458 million for the acquisition of property, plant and equipment and ¥189 million for the acquisition of intangible assets. - FY2020-Q1AdvancedAnnual report
「The group's total R&D expenditure for the current first-quarter cumulative consolidated period was ¥89 million.」
R&D expenditure of ¥89 million for the current first-quarter cumulative consolidated period was disclosed, and investment in R&D is continuing. - FY2019-Q3AdvancedAnnual report
「The group's total R&D expenditure for the current third-quarter cumulative consolidated period was ¥251 million, of which ¥87 million related to the US R&D Center.」
R&D expenditure of ¥251 million for the third-quarter cumulative consolidated period and ¥87 million in costs related to the US R&D Center were disclosed. - FY2019-Q2AdvancedAnnual report
「The Group's total R&D expenditure during the six-month period ended the second quarter was ¥170 million.」
R&D expenditure for the current second-quarter cumulative consolidated period was disclosed at ¥170 million, and investment in R&D is continuing. Capital expenditures also included ¥1,289 million for the acquisition of property, plant and equipment. - FY2019-Q1AdvancedAnnual report
「The Group’s total research and development expenditure for the cumulative first quarter was ¥75 million.」
The Company disclosed R&D expenditure of ¥75 million for the cumulative first-quarter period. - FY2018AdvancedAnnual report
「Total capital investment in the semiconductor device business during the current fiscal year was ¥1,150.428 million. Major investments included software and related equipment for new product development, quality assurance facilities to address target markets, and plant integration to improve production efficiency.」
The Company disclosed full-year capital investment of ¥1,150 million and advanced investments in new product development, quality assurance facilities and plant integration. R&D expenses were also ¥405 million. - FY2018-Q3AdvancedAnnual report
「The Group's total R&D expenditure during the nine-month period ended the third quarter was ¥296 million, of which ¥87 million related to the U.S. R&D Center.」
The Company disclosed R&D expenditure of ¥296 million for the cumulative nine-month period ended the third quarter, including ¥87 million related to the U.S. R&D Center. - FY2018-Q2AdvancedAnnual report
「The Group's total R&D expenditure during the six-month period ended the second quarter was ¥199 million, of which ¥60 million related to the U.S. R&D Center.」
The Company disclosed cumulative R&D expenditure of ¥199 million, of which ¥60 million related to the U.S. R&D Center. - FY2018-Q1AdvancedAnnual report
「The Group's total R&D expenditure during the three-month period ended the first quarter was ¥79 million.」
The Company disclosed R&D expenditure of ¥79 million for the cumulative first-quarter period. - FY2017-Q3AdvancedAnnual report
「The Group's total R&D expenditure during the nine-month period ended the third quarter was ¥147 million, all of which was incurred by the Japan segment.」
The Company disclosed cumulative R&D expenditure of ¥147 million. The cumulative amount increased from ¥94 million for the six-month period ended the second quarter. - FY2017-Q2AdvancedAnnual report
「The Group's total R&D expenditure during the six-month period ended the second quarter was ¥94 million, all of which was incurred by the Japan segment.」
The Company reported R&D expenses of ¥94 million and capital investment expenditure of ¥622.945 million for the acquisition of property, plant and equipment. - FY2017-Q1Additional capital investment and repair plansAnnual report
「As PTS was included in the scope of consolidation, ¥954 million for its capital investment plan was added.」
Following the consolidation of フェニテックセミコンダクター, a capital investment plan of ¥954 million and a repair plan of ¥593 million were added to the Group's plans. - FY2016First statedAnnual report
「The Company will identify overlapping processes, capital investments and other items within the Group and optimize Group-wide assets and improve the efficiency of invested capital.」
The Company’s policy is to improve the efficiency of Group assets and invested capital while balancing shareholder returns with growth investment.